Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brian Bossetta

Senior Writer, US Policy & Regulation

New York, NY
After moving to New York from his hometown of New Orleans, Brian worked on the East End of Long Island covering news, politics and the military. He has since covered the diamond and jewelry industries and most recently pharmacy and healthcare. His experience also includes freelance reporting and photography contributed to the New York Times.

Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley. 

Latest From Brian Bossetta

Hear! Hear! Industry Responds To FDA Proposal On OTC Hearing Aids

The FDA’s recent proposal to allow hearing aids to be sold over the counter without a prescription has mostly been met with approval. Many Americans, however, are unaware of the plan.

FDA OTC Devices

AdvaMed Urges CMS To Leave MCIT In Place

In a letter to CMS Administrator Chiquita Brooks-LaSure, the industry association argues that repealing MCIT would deny many Americans access to “transformational” medical technologies.

Medicare Innovation

Democratic Lawmakers Want ACA Contraceptive Coverage Enforced

The Affordable Care Act requires health insurers to cover contraceptives; some lawmakers in the US House want to make sure those requirements are upheld.

Legislation Policy

FDA Warns Of Overdose Risk For ENFit Syringes

The US FDA issued a safety communication to patients and health care providers about the potential for overdose when using ENFit low dose tip syringes, and also told manufacturers to update labeling to account for the risk.

Safety FDA

FDA Updates Guidance On Unique Device Identification Labeling For Class I Devices

The US FDA’s most recent guidance revises UDI requirements for class I and unclassified medical devices the agency issued in July. Class I devices categorized as consumer health products will be exempt from some submission requirements.

FDA Regulation

US Appellate Court Hands Siemens Big Win In False Advertising Suit

The Ninth Circuit Court of Appeals upheld a lower court’s decision that false advertising claims made against Siemens Medical Solutions by a competitor had no basis for trial.

Legal Issues Diagnostics
See All
UsernamePublicRestriction

Register